The current valuation score of Sol Gel Technologies Ltd is 9.47, ranking 16 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -37.40, which is -753.25% below the recent high of 244.30 and -120.47% above the recent low of -82.45.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.